QUETIAPINE FUMARATE

QUETIAPINE FUMARATE was reported 30130 times

QUETIAPINE FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PROLACTIN ABNORMAL 427 0.4948
1 ANOSOGNOSIA 374 0.4870
2 LUPUS VULGARIS 548 0.4349
3 HEPATIC ENZYME 63 0.4228
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 249 0.3728
5 HYPOCHOLESTEROLAEMIA 122 0.3456
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 660 0.3295
7 GRIP STRENGTH 71 0.3100
8 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 165 0.2941
9 TENDER JOINT COUNT 24 0.2857
10 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 30 0.2857
11 RETINITIS 473 0.2736
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 544 0.2623
13 SWOLLEN JOINT COUNT INCREASED 816 0.2556
14 DISLOCATION OF VERTEBRA 559 0.2449
15 SWOLLEN JOINT COUNT 61 0.2440
16 RHEUMATIC FEVER 1043 0.2338
17 TOTAL LUNG CAPACITY INCREASED 63 0.2316
18 MYOGLOBIN URINE PRESENT 56 0.2276
19 C-REACTIVE PROTEIN 202 0.2179
20 STUBBORNNESS 86 0.1995
21 X-RAY ABNORMAL 349 0.1950
22 RHEUMATOID FACTOR POSITIVE 1071 0.1852
23 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 23 0.1840
24 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 126 0.1823
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1305 0.1820
26 SERONEGATIVE ARTHRITIS 197 0.1719
27 DUODENAL ULCER PERFORATION 1247 0.1675
28 FACET JOINT SYNDROME 536 0.1645
29 PERIPHERAL VENOUS DISEASE 671 0.1641
30 DISTURBANCE IN SOCIAL BEHAVIOUR 368 0.1561
31 PEMPHIGUS 1913 0.1529
32 DELUSIONAL DISORDER, PERSECUTORY TYPE 63 0.1504
33 GROWTH HORMONE DEFICIENCY 57 0.1436
34 MUSCLE INJURY 1151 0.1388
35 PORPHYRIA ACUTE 186 0.1296
36 HELICOBACTER INFECTION 1307 0.1270
37 TEMPERATURE REGULATION DISORDER 269 0.1206
38 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 63 0.1205
39 HAND DEFORMITY 1498 0.1141
40 ORTHOSTATIC HYPERTENSION 63 0.1081
41 FOLLICULITIS 1089 0.1037
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 660 0.1015
43 OVERLAP SYNDROME 69 0.0986
44 BREAST CANCER STAGE III 625 0.0964
45 PERICARDITIS 1579 0.0939
46 BONE EROSION 324 0.0915
47 C-REACTIVE PROTEIN ABNORMAL 576 0.0897
48 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 76 0.0820
49 JOINT RANGE OF MOTION DECREASED 1068 0.0796
50 LIP DRY 716 0.0788
51 HYPERCHOLESTEROLAEMIA 760 0.0786
52 SYNOVITIS 1418 0.0786
53 GLOSSODYNIA 1752 0.0782
54 WOUND INFECTION 856 0.0781
55 METABOLIC DISORDER 447 0.0769
56 PRESCRIBED OVERDOSE 1433 0.0740
57 ANTICHOLINERGIC SYNDROME 117 0.0734
58 DRUG TOLERANCE DECREASED 203 0.0722
59 BURSITIS 875 0.0720
60 DISINHIBITION 112 0.0695
61 LIVER INJURY 1705 0.0694
62 AUTOIMMUNE DISORDER 655 0.0671
63 JOINT DESTRUCTION 100 0.0643
64 PSYCHIATRIC DECOMPENSATION 125 0.0639
65 WOUND 1743 0.0623
66 FOETAL DEATH 313 0.0603
67 METABOLIC SYNDROME 94 0.0572
68 GRIP STRENGTH DECREASED 499 0.0566
69 IRRITABLE BOWEL SYNDROME 1209 0.0563
70 LIVE BIRTH 464 0.0554
71 OBESITY 868 0.0544
72 COGWHEEL RIGIDITY 57 0.0543
73 SYSTEMIC LUPUS ERYTHEMATOSUS 1800 0.0507
74 DEATH NEONATAL 70 0.0503
75 PUSTULAR PSORIASIS 172 0.0500
76 HYPOMANIA 184 0.0500
77 BLEPHAROSPASM 315 0.0500
78 FIBROMYALGIA 1205 0.0495
79 PULMONARY FIBROSIS 947 0.0493
80 MULTIPLE DRUG THERAPY 37 0.0491
81 FOOD ALLERGY 378 0.0489
82 CONTRAINDICATED PRODUCT ADMINISTERED 1465 0.0483
83 BEZOAR 66 0.0478
84 TOTAL LUNG CAPACITY DECREASED 74 0.0463
85 LUPUS-LIKE SYNDROME 416 0.0458
86 PSORIATIC ARTHROPATHY 1790 0.0441
87 SCHIZOPHRENIA 530 0.0436
88 LOWER LIMB FRACTURE 831 0.0432
89 SCHIZOAFFECTIVE DISORDER 77 0.0431
90 WALKING AID USER 282 0.0427
91 PITUITARY TUMOUR BENIGN 69 0.0423
92 TYPE 2 DIABETES MELLITUS 1421 0.0422
93 EXOSTOSIS 382 0.0418
94 HALLUCINATIONS, MIXED 171 0.0406
95 SCIATICA 643 0.0403
96 PERSONALITY CHANGE 374 0.0402
97 SEXUAL DYSFUNCTION 472 0.0402
98 RED BLOOD CELL SEDIMENTATION RATE INCREASED 441 0.0398
99 PSYCHOMOTOR SKILLS IMPAIRED 104 0.0397
100 NEUROLEPTIC MALIGNANT SYNDROME 463 0.0390
101 PNEUMOCOCCAL INFECTION 23 0.0389
102 OCULOGYRIC CRISIS 81 0.0377
103 PRESCRIBED UNDERDOSE 748 0.0375
104 JOINT DISLOCATION 388 0.0367
105 SLEEP-RELATED EATING DISORDER 34 0.0363
106 IMPAIRED HEALING 1191 0.0362
107 DISCOLOURED VOMIT 34 0.0354
108 PRIAPISM 121 0.0351
109 SEDATION 905 0.0345
110 RASH VESICULAR 164 0.0339
111 SOPOR 440 0.0332
112 INFUSION SITE REACTION 98 0.0328
113 DEPRESSIVE SYMPTOM 115 0.0326
114 FOOT DEFORMITY 359 0.0324
115 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 21 0.0323
116 DYSTONIA 617 0.0318
117 BREAST CANCER STAGE II 264 0.0317
118 EYE INJURY 96 0.0316
119 ULCER HAEMORRHAGE 213 0.0314
120 NAIL DISORDER 275 0.0314
121 EMOTIONAL POVERTY 55 0.0314
122 ACCIDENTAL POISONING 43 0.0313
123 DEPRESSION SUICIDAL 107 0.0309
124 JAUNDICE CHOLESTATIC 109 0.0308
125 EOSINOPHIL COUNT ABNORMAL 23 0.0308
126 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 523 0.0305
127 IMMUNODEFICIENCY 452 0.0303
128 GASTRIC PH DECREASED 31 0.0302
129 SPONDYLITIS 108 0.0297
130 HIP ARTHROPLASTY 451 0.0294
131 LABELLED DRUG-DRUG INTERACTION ISSUE 42 0.0290
132 OROMANDIBULAR DYSTONIA 21 0.0288
133 COMA SCALE ABNORMAL 83 0.0286
134 LUNG OPACITY 75 0.0284
135 ARTHROPATHY 1550 0.0279
136 SEDATION COMPLICATION 70 0.0274
137 BLOOD CHOLESTEROL INCREASED 1276 0.0273
138 HEPATIC ENZYME INCREASED 1793 0.0263
139 INFUSION RELATED REACTION 1716 0.0259
140 PARKINSONISM 252 0.0258
141 ELECTRIC SHOCK 22 0.0257
142 MATERNAL EXPOSURE TIMING UNSPECIFIED 96 0.0255
143 THERAPEUTIC PRODUCT EFFECT VARIABLE 99 0.0255
144 COELIAC DISEASE 249 0.0254
145 DELIRIUM 880 0.0253
146 LOWER RESPIRATORY TRACT INFECTION 1149 0.0252
147 AKATHISIA 339 0.0248
148 OSTEOARTHRITIS 1049 0.0247
149 GAIT INABILITY 815 0.0244
150 ISCHAEMIC CEREBRAL INFARCTION 28 0.0241
151 TEARFULNESS 102 0.0237
152 NIGHT SWEATS 755 0.0234
153 WHEEZING 1383 0.0233
154 PLEUROTHOTONUS 21 0.0232
155 DYSLIPIDAEMIA 117 0.0230
156 APRAXIA 34 0.0229
157 PERSECUTORY DELUSION 57 0.0228
158 OBSESSIVE-COMPULSIVE DISORDER 181 0.0225
159 EXPOSURE DURING PREGNANCY 1399 0.0225
160 PLEURITIC PAIN 62 0.0224
161 RESTRICTIVE PULMONARY DISEASE 26 0.0222
162 SUICIDE ATTEMPT 1336 0.0220
163 HEPATIC CIRRHOSIS 413 0.0220
164 VENTRICULAR DYSFUNCTION 57 0.0219
165 BLOOD PRESSURE SYSTOLIC ABNORMAL 54 0.0218
166 POSTURE ABNORMAL 71 0.0218
167 DISCOMFORT 1325 0.0217
168 HYPERREFLEXIA 75 0.0215
169 BRONCHIECTASIS 145 0.0215
170 BLISTER 1203 0.0214
171 IMPULSE-CONTROL DISORDER 44 0.0214
172 SOMATIC SYMPTOM DISORDER 23 0.0213
173 OEDEMA 1141 0.0210
174 ONYCHOMADESIS 86 0.0205
175 BLADDER PROLAPSE 25 0.0204
176 PSYCHOMOTOR RETARDATION 57 0.0203
177 CATATONIA 106 0.0202
178 RECTAL PROLAPSE 24 0.0199
179 GENERAL SYMPTOM 148 0.0197
180 KNEE ARTHROPLASTY 415 0.0197
181 DRUG TOLERANCE 99 0.0195
182 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 45 0.0195
183 POISONING DELIBERATE 185 0.0195
184 BLOOD PROLACTIN INCREASED 92 0.0195
185 SEROTONIN SYNDROME 372 0.0193
186 RHEUMATOID ARTHRITIS 2189 0.0193
187 ROAD TRAFFIC ACCIDENT 805 0.0192
188 STOMATITIS 1154 0.0190
189 COMPLETED SUICIDE 1573 0.0189
190 MATERNAL EXPOSURE DURING PREGNANCY 1676 0.0188
191 MULTIPLE DRUG OVERDOSE 93 0.0187
192 MYOSITIS 168 0.0187
193 DEREALISATION 40 0.0186
194 H1N1 INFLUENZA 26 0.0185
195 ASPIRATION 199 0.0182
196 THERAPEUTIC PRODUCT EFFECT DECREASED 812 0.0181
197 PSYCHOTIC SYMPTOM 37 0.0179
198 THERMAL BURN 127 0.0179
199 SPINAL FUSION SURGERY 72 0.0177
200 DYSKINESIA 714 0.0176
201 NASAL DISCHARGE DISCOLOURATION 24 0.0174
202 PSYCHOTIC DISORDER 514 0.0174
203 C-REACTIVE PROTEIN INCREASED 628 0.0172
204 BRADYPHRENIA 111 0.0170
205 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 87 0.0170
206 BLOOD PRESSURE DIASTOLIC ABNORMAL 43 0.0169
207 DISORGANISED SPEECH 31 0.0168
208 TASTE DISORDER 341 0.0168
209 GESTATIONAL DIABETES 80 0.0168
210 RALES 97 0.0167
211 VASOPLEGIA SYNDROME 27 0.0165
212 MOBILITY DECREASED 1163 0.0162
213 DRUG INTOLERANCE 1560 0.0161
214 MUSCULOSKELETAL STIFFNESS 1411 0.0161
215 BRADYKINESIA 95 0.0161
216 LIVER FUNCTION TEST INCREASED 344 0.0160
217 JOINT STIFFNESS 420 0.0160
218 NORMAL NEWBORN 87 0.0160
219 HEAD TITUBATION 22 0.0160
220 AMYLASE INCREASED 59 0.0160
221 GAZE PALSY 27 0.0158
222 SWELLING 1481 0.0158
223 MUSCLE RIGIDITY 187 0.0156
224 LUNG DISORDER 765 0.0156
225 MUSCULOSKELETAL PAIN 812 0.0155
226 HALLUCINATION, AUDITORY 245 0.0154
227 POLYARTHRITIS 81 0.0153
228 TERMINAL INSOMNIA 27 0.0152
229 TROPONIN INCREASED 116 0.0152
230 MULTIPLE DRUG OVERDOSE INTENTIONAL 49 0.0152
231 TOXIC ENCEPHALOPATHY 77 0.0152
232 INJURY 1067 0.0152
233 UPPER RESPIRATORY TRACT INFECTION 699 0.0151
234 PARANOIA 258 0.0150
235 ALCOHOL ABUSE 40 0.0149
236 THERAPY NON-RESPONDER 665 0.0148
237 MANIA 242 0.0147
238 JOINT SWELLING 1772 0.0147
239 INTENTIONAL SELF-INJURY 295 0.0146
240 PUPILLARY REFLEX IMPAIRED 27 0.0146
241 SLOW SPEECH 35 0.0144
242 RHINITIS ALLERGIC 64 0.0144
243 EXCESSIVE EYE BLINKING 21 0.0142
244 ELECTROCARDIOGRAM QT PROLONGED 511 0.0142
245 INTENTIONAL MISUSE 27 0.0141
246 DELUSION 218 0.0140
247 DISABILITY 277 0.0140
248 ACCIDENTAL DEATH 26 0.0140
249 TREATMENT FAILURE 1157 0.0140
250 CLONUS 38 0.0139
251 ANTIPSYCHOTIC DRUG LEVEL INCREASED 39 0.0138
252 EAR INFECTION 367 0.0138
253 EUPHORIC MOOD 139 0.0136
254 SARCOIDOSIS 64 0.0135
255 INTENTIONAL PRODUCT USE ISSUE 1180 0.0135
256 GENERAL PHYSICAL HEALTH DETERIORATION 1547 0.0134
257 INTENTIONAL OVERDOSE 843 0.0131
258 OSTEOPOROSIS 540 0.0131
259 SINUS TACHYCARDIA 186 0.0131
260 SLEEP DISORDER 920 0.0130
261 MYOCARDITIS 149 0.0130
262 TOXICITY TO VARIOUS AGENTS 2192 0.0130
263 CLEFT PALATE 25 0.0129
264 BACK DISORDER 210 0.0129
265 DIABETES INSIPIDUS 31 0.0129
266 HYPERPROLACTINAEMIA 83 0.0128
267 NASAL POLYPS 63 0.0128
268 INFARCTION 87 0.0127
269 LIVER DISORDER 562 0.0127
270 EPILEPSY 386 0.0126
271 DRUG LEVEL BELOW THERAPEUTIC 69 0.0125
272 INFLAMMATION 637 0.0123
273 BIPOLAR I DISORDER 27 0.0123
274 POISONING 154 0.0122
275 WOUND COMPLICATION 42 0.0122
276 POLYDIPSIA 48 0.0121
277 STUPOR 39 0.0121
278 BACK INJURY 132 0.0121
279 SUBSTANCE ABUSE 98 0.0120
280 ANXIETY DISORDER 40 0.0120
281 LOGORRHOEA 42 0.0119
282 PREGNANCY 238 0.0119
283 DRUG INTERACTION 1876 0.0118
284 DEPRESSED LEVEL OF CONSCIOUSNESS 462 0.0117
285 CONGENITAL ANOMALY 90 0.0116
286 MEAN CELL HAEMOGLOBIN DECREASED 21 0.0115
287 DRUG ABUSE 951 0.0114
288 RESPIRATORY DEPRESSION 140 0.0114
289 ACUTE PSYCHOSIS 28 0.0113
290 FAECALOMA 62 0.0113
291 BIPOLAR DISORDER 123 0.0113
292 FLUID RETENTION 570 0.0112
293 ALCOHOL POISONING 30 0.0112
294 ABDOMINAL DISCOMFORT 1861 0.0111
295 HALLUCINATION, VISUAL 234 0.0111
296 CONFUSIONAL STATE 1778 0.0110
297 OBSTRUCTIVE AIRWAYS DISORDER 122 0.0110
298 EOSINOPHIL COUNT DECREASED 26 0.0109
299 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 518 0.0108
300 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 183 0.0108
301 POTENTIATING DRUG INTERACTION 36 0.0107
302 CONTUSION 1032 0.0107
303 DRUG TOXICITY 146 0.0107
304 AMNESIA 687 0.0105
305 DRY MOUTH 856 0.0105
306 ASTHMA 1191 0.0105
307 ILL-DEFINED DISORDER 637 0.0105
308 EXTRAPYRAMIDAL DISORDER 255 0.0103
309 COMA 483 0.0101
310 TORSADE DE POINTES 79 0.0101
311 BRAIN HERNIATION 30 0.0100
312 RESTLESS LEGS SYNDROME 181 0.0099
313 STARING 24 0.0099
314 PERSONALITY DISORDER 26 0.0099
315 PRODUCT USE ISSUE 1858 0.0099
316 VENTRICULAR ARRHYTHMIA 36 0.0098
317 MIOSIS 77 0.0096
318 ONYCHOMYCOSIS 42 0.0096
319 WEIGHT INCREASED 2143 0.0096
320 WRONG PATIENT RECEIVED PRODUCT 28 0.0096
321 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 21 0.0095
322 ALTERED STATE OF CONSCIOUSNESS 202 0.0093
323 HYPERTENSION 1971 0.0093
324 SALIVARY HYPERSECRETION 92 0.0092
325 FORCED EXPIRATORY VOLUME DECREASED 26 0.0092
326 ALOPECIA 1800 0.0092
327 SINUSITIS 939 0.0092
328 INFECTION 1323 0.0091
329 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 30 0.0090
330 HYPERTRANSAMINASAEMIA 63 0.0090
331 BLOOD CREATINE PHOSPHOKINASE INCREASED 260 0.0090
332 BLOOD CALCIUM INCREASED 79 0.0090
333 AREFLEXIA 24 0.0090
334 WEIGHT FLUCTUATION 94 0.0090
335 ENURESIS 36 0.0089
336 BRADYPNOEA 24 0.0089
337 DRUG-INDUCED LIVER INJURY 278 0.0089
338 THINKING ABNORMAL 165 0.0088
339 SOMNAMBULISM 58 0.0088
340 PERIPHERAL SWELLING 1354 0.0088
341 CARDIAC MURMUR 76 0.0088
342 HYPOAESTHESIA 1314 0.0088
343 LONG QT SYNDROME 21 0.0088
344 MAJOR DEPRESSION 64 0.0087
345 MYOCLONUS 104 0.0087
346 SPUTUM DISCOLOURED 82 0.0086
347 PROTEIN TOTAL INCREASED 23 0.0086
348 HYPERSENSITIVITY 1596 0.0086
349 GALACTORRHOEA 55 0.0086
350 RESPIRATORY ARREST 236 0.0086
351 FREQUENT BOWEL MOVEMENTS 231 0.0085
352 BLOOD LACTIC ACID INCREASED 45 0.0085
353 DROOLING 59 0.0085
354 MATERNAL EXPOSURE BEFORE PREGNANCY 58 0.0085
355 PNEUMONIA ASPIRATION 212 0.0085
356 MEMORY IMPAIRMENT 1157 0.0084
357 SUICIDAL IDEATION 769 0.0084
358 OEDEMA PERIPHERAL 1013 0.0083
359 HYPERTHERMIA 63 0.0082
360 AUTONOMIC NERVOUS SYSTEM IMBALANCE 24 0.0082
361 SUSPECTED OFF LABEL USE 37 0.0082
362 DEPRESSION 1860 0.0082
363 LEFT VENTRICULAR FAILURE 28 0.0081
364 PSYCHIATRIC SYMPTOM 60 0.0081
365 BRAIN INJURY 81 0.0081
366 DRUG LEVEL ABOVE THERAPEUTIC 37 0.0081
367 TACHYCARDIA 717 0.0081
368 INCREASED APPETITE 154 0.0081
369 MIGRAINE 769 0.0080
370 DYSPEPSIA 790 0.0080
371 MYDRIASIS 103 0.0080
372 HYPERAMMONAEMIA 40 0.0080
373 RESPIRATORY RATE DECREASED 25 0.0080
374 BEHAVIOUR DISORDER 43 0.0079
375 SUICIDAL BEHAVIOUR 33 0.0079
376 NASOPHARYNGITIS 1458 0.0079
377 UNRESPONSIVE TO STIMULI 204 0.0079
378 GASTROINTESTINAL DISORDER 702 0.0078
379 ADVERSE DRUG REACTION 702 0.0078
380 DRUG LEVEL INCREASED 129 0.0078
381 APATHY 113 0.0077
382 TALIPES 24 0.0077
383 GRANULOCYTOPENIA 44 0.0077
384 URTICARIA 1294 0.0077
385 FEELING OF DESPAIR 36 0.0077
386 MONOCYTE COUNT INCREASED 28 0.0077
387 LEUKOPENIA 385 0.0077
388 ORTHOSTATIC HYPOTENSION 133 0.0076
389 HYPERCAPNIA 23 0.0076
390 RASH ERYTHEMATOUS 364 0.0076
391 PARADOXICAL DRUG REACTION 28 0.0076
392 DRUG SCREEN FALSE POSITIVE 21 0.0076
393 AGITATION 556 0.0076
394 CARDIO-RESPIRATORY ARREST 313 0.0075
395 EAR PAIN 145 0.0075
396 RESTLESSNESS 272 0.0074
397 CONDITION AGGRAVATED 2242 0.0074
398 ADRENAL INSUFFICIENCY 89 0.0073
399 DISSOCIATION 56 0.0073
400 DECREASED IMMUNE RESPONSIVENESS 71 0.0072
401 HYPOTHERMIA 73 0.0072
402 IMPULSIVE BEHAVIOUR 27 0.0072
403 HYPERTRIGLYCERIDAEMIA 42 0.0072
404 PSYCHOMOTOR HYPERACTIVITY 119 0.0072
405 BLOOD CHOLESTEROL ABNORMAL 33 0.0071
406 HALLUCINATION 538 0.0071
407 RESPIRATORY ACIDOSIS 28 0.0071
408 INTENTIONAL PRODUCT MISUSE 623 0.0071
409 ABNORMAL BEHAVIOUR 281 0.0071
410 AGGRESSION 354 0.0071
411 TARDIVE DYSKINESIA 197 0.0070
412 INSURANCE ISSUE 106 0.0069
413 HOMICIDAL IDEATION 28 0.0069
414 OVERWEIGHT 37 0.0069
415 AFFECTIVE DISORDER 54 0.0069
416 STATUS EPILEPTICUS 77 0.0068
417 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 484 0.0068
418 HYPERPHAGIA 27 0.0068
419 ELECTROCARDIOGRAM ABNORMAL 53 0.0067
420 WHITE BLOOD CELL COUNT INCREASED 257 0.0067
421 PSORIASIS 870 0.0067
422 RESPIRATORY DISORDER 199 0.0066
423 ELECTROENCEPHALOGRAM ABNORMAL 21 0.0066
424 NEUROLOGICAL SYMPTOM 38 0.0066
425 MEDICATION ERROR 368 0.0066
426 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 67 0.0065
427 OVERDOSE 1397 0.0065
428 SELF-INJURIOUS IDEATION 27 0.0064
429 BLOOD TEST ABNORMAL 90 0.0064
430 VENTRICULAR FIBRILLATION 71 0.0064
431 THROMBOTIC THROMBOCYTOPENIC PURPURA 22 0.0062
432 BLOOD PRESSURE DIASTOLIC DECREASED 46 0.0062
433 THERAPEUTIC PRODUCT INEFFECTIVE 24 0.0062
434 RHABDOMYOLYSIS 256 0.0061
435 DECREASED INTEREST 36 0.0061
436 GASTROOESOPHAGEAL REFLUX DISEASE 489 0.0061
437 BLOOD PRESSURE DIASTOLIC INCREASED 28 0.0061
438 TACHYPHRENIA 21 0.0061
439 SOCIAL AVOIDANT BEHAVIOUR 35 0.0060
440 INJECTION SITE INFLAMMATION 30 0.0060
441 COMMUNICATION DISORDER 23 0.0060
442 PRODUCT USE IN UNAPPROVED INDICATION 1488 0.0060
443 PANCREATITIS 317 0.0060
444 FLANK PAIN 56 0.0060
445 APNOEA 46 0.0059
446 BUNDLE BRANCH BLOCK LEFT 25 0.0059
447 ADVERSE EVENT 538 0.0058
448 ABDOMINAL PAIN UPPER 1201 0.0058
449 MENTAL IMPAIRMENT 141 0.0058
450 MOOD ALTERED 158 0.0058
451 COLITIS ISCHAEMIC 39 0.0058
452 GASTRIC INFECTION 22 0.0057
453 HEPATOTOXICITY 128 0.0057
454 DECREASED APPETITE 1333 0.0057
455 HYPERSOMNIA 164 0.0057
456 SOMNOLENCE 1149 0.0057
457 POST-TRAUMATIC STRESS DISORDER 38 0.0057
458 BUNDLE BRANCH BLOCK RIGHT 26 0.0057
459 PREMATURE LABOUR 32 0.0057
460 HYPOKINESIA 82 0.0056
461 TREATMENT NONCOMPLIANCE 309 0.0056
462 FEELING OF BODY TEMPERATURE CHANGE 33 0.0056
463 HYPERHIDROSIS 725 0.0056
464 HYPOXIA 197 0.0056
465 PAROSMIA 42 0.0056
466 LEUKAEMIA 52 0.0055
467 PYREXIA 1906 0.0055
468 PULSELESS ELECTRICAL ACTIVITY 23 0.0055
469 PARAESTHESIA 864 0.0055
470 URINARY RETENTION 183 0.0055
471 COLITIS ULCERATIVE 245 0.0055
472 WRONG PRODUCT ADMINISTERED 37 0.0055
473 DYSPHEMIA 24 0.0055
474 CHOLELITHIASIS 179 0.0055
475 CHEST PAIN 1009 0.0054
476 HYPERNATRAEMIA 27 0.0054
477 ARTHRITIS 425 0.0054
478 ILEUS PARALYTIC 24 0.0054
479 ACUTE PULMONARY OEDEMA 30 0.0053
480 SCREAMING 34 0.0053
481 ANXIETY 1518 0.0053
482 PRODUCT LABEL CONFUSION 31 0.0053
483 BLOOD POTASSIUM INCREASED 86 0.0053
484 ARTERIOSCLEROSIS CORONARY ARTERY 35 0.0053
485 HYPERTONIA 30 0.0052
486 COGNITIVE DISORDER 244 0.0052
487 BRAIN OEDEMA 66 0.0052
488 HEART RATE ABNORMAL 29 0.0052
489 MENSTRUAL DISORDER 43 0.0052
490 ENCEPHALOPATHY 127 0.0052
491 CORONARY ARTERY STENOSIS 26 0.0052
492 FOOD CRAVING 27 0.0051
493 INCONTINENCE 54 0.0051
494 MUSCULAR WEAKNESS 580 0.0051
495 PNEUMONIA 1645 0.0051
496 RECTAL HAEMORRHAGE 218 0.0051
497 TRISMUS 26 0.0050
498 DISORIENTATION 199 0.0050
499 BRUXISM 27 0.0050
500 THERAPEUTIC RESPONSE DECREASED 303 0.0050
501 BLOOD LACTATE DEHYDROGENASE INCREASED 79 0.0050
502 MENTAL STATUS CHANGES 138 0.0050
503 TIC 27 0.0049
504 INCOHERENT 32 0.0049
505 RASH 2153 0.0049
506 LUNG NEOPLASM 21 0.0049
507 HYPOKALAEMIA 225 0.0049
508 BLOOD BILIRUBIN INCREASED 131 0.0048
509 SPEECH DISORDER 254 0.0048
510 BLOOD PRESSURE SYSTOLIC DECREASED 22 0.0048
511 THERAPY PARTIAL RESPONDER 75 0.0048
512 BODY TEMPERATURE INCREASED 98 0.0048
513 MUSCLE SPASMS 880 0.0048
514 ANAL INCONTINENCE 43 0.0048
515 CONCUSSION 37 0.0048
516 CARDIAC ARREST 394 0.0048
517 GAIT DISTURBANCE 909 0.0047
518 DYSARTHRIA 178 0.0047
519 TRANSAMINASES INCREASED 105 0.0047
520 VISUAL IMPAIRMENT 581 0.0047
521 THROMBOCYTOPENIA 523 0.0047
522 MENTAL DISORDER 203 0.0047
523 SMALL FOR DATES BABY 23 0.0046
524 PULMONARY MASS 69 0.0046
525 INITIAL INSOMNIA 47 0.0046
526 PAIN 2811 0.0046
527 VITAMIN D DECREASED 39 0.0046
528 DEMENTIA 127 0.0045
529 URINARY INCONTINENCE 134 0.0045
530 VOMITING 2122 0.0045
531 FOETAL EXPOSURE DURING PREGNANCY 366 0.0045
532 EMPHYSEMA 45 0.0045
533 DECREASED ACTIVITY 48 0.0044
534 MUSCLE DISORDER 36 0.0044
535 TENSION 27 0.0044
536 POLYURIA 36 0.0044
537 HEPATIC CYTOLYSIS 56 0.0044
538 FEELING HOT 269 0.0044
539 TREMOR 728 0.0044
540 INSOMNIA 1168 0.0044
541 DRUG DIVERSION 27 0.0044
542 STAPHYLOCOCCAL INFECTION 144 0.0044
543 SLEEP APNOEA SYNDROME 83 0.0043
544 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
545 LOSS OF CONSCIOUSNESS 556 0.0043
546 ACIDOSIS 33 0.0043
547 BLOOD PRESSURE SYSTOLIC INCREASED 84 0.0043
548 NIGHTMARE 149 0.0043
549 HYPOTENSION 862 0.0043
550 NODULE 56 0.0043
551 BRONCHITIS 316 0.0043
552 ACCIDENTAL OVERDOSE 156 0.0043
553 BLOOD SODIUM DECREASED 80 0.0042
554 PLATELET COUNT INCREASED 55 0.0042
555 ATAXIA 50 0.0042
556 HYPOTONIA 42 0.0042
557 CARDIOMYOPATHY 62 0.0042
558 RETCHING 89 0.0042
559 PANIC REACTION 30 0.0042
560 SKIN LACERATION 45 0.0041
561 LOSS OF LIBIDO 37 0.0041
562 SENSORY LOSS 33 0.0041
563 SHOCK 93 0.0040
564 WITHDRAWAL SYNDROME 168 0.0040
565 HEPATITIS ACUTE 26 0.0040
566 BLOOD PRESSURE FLUCTUATION 96 0.0040
567 POOR QUALITY SLEEP 86 0.0040
568 BREAST CANCER STAGE I 37 0.0040
569 HYPONATRAEMIA 224 0.0040
570 RHINITIS 32 0.0040
571 NYSTAGMUS 21 0.0040
572 ARTHRALGIA 1645 0.0040
573 INTENTIONAL DRUG MISUSE 82 0.0039
574 MIDDLE INSOMNIA 73 0.0039
575 UNDERDOSE 285 0.0039
576 DISTURBANCE IN ATTENTION 210 0.0039
577 ABNORMAL WEIGHT GAIN 48 0.0039
578 HAEMATOCRIT DECREASED 77 0.0039
579 ANGER 130 0.0038
580 SINUS BRADYCARDIA 37 0.0038
581 TACHYPNOEA 52 0.0038
582 HAEMODYNAMIC INSTABILITY 29 0.0038
583 DECUBITUS ULCER 31 0.0038
584 OFF LABEL USE 3330 0.0038
585 DIZZINESS 1896 0.0038
586 BLOOD TRIGLYCERIDES INCREASED 67 0.0038
587 IRRITABILITY 227 0.0038
588 LABORATORY TEST ABNORMAL 111 0.0038
589 CIRCULATORY COLLAPSE 64 0.0038
590 DRUG ABUSER 23 0.0037
591 DEPRESSED MOOD 197 0.0037
592 METABOLIC ACIDOSIS 119 0.0037
593 AGRANULOCYTOSIS 69 0.0037
594 DIABETES MELLITUS 281 0.0037
595 REFUSAL OF TREATMENT BY PATIENT 24 0.0037
596 BODY TEMPERATURE DECREASED 36 0.0037
597 COORDINATION ABNORMAL 51 0.0037
598 MATERNAL DRUGS AFFECTING FOETUS 28 0.0036
599 AMENORRHOEA 64 0.0036
600 DRUG LEVEL DECREASED 37 0.0036
601 FATIGUE 2819 0.0036
602 PRESYNCOPE 88 0.0036
603 SCRATCH 38 0.0036
604 MUSCLE TWITCHING 83 0.0036
605 POOR VENOUS ACCESS 37 0.0036
606 CYANOSIS 56 0.0036
607 BLOOD GLUCOSE FLUCTUATION 39 0.0036
608 PAIN IN EXTREMITY 1044 0.0035
609 APHASIA 107 0.0035
610 DRUG SCREEN POSITIVE 28 0.0035
611 TOOTH ABSCESS 36 0.0035
612 MOTOR DYSFUNCTION 36 0.0035
613 ACCIDENT 42 0.0035
614 HEADACHE 2204 0.0035
615 HAEMOPTYSIS 98 0.0035
616 DRUG WITHDRAWAL SYNDROME NEONATAL 52 0.0035
617 SYMPTOM RECURRENCE 21 0.0035
618 GENERALISED TONIC-CLONIC SEIZURE 58 0.0035
619 SUDDEN DEATH 37 0.0035
620 VERTIGO 213 0.0035
621 PARALYSIS 50 0.0035
622 HEPATIC STEATOSIS 65 0.0035
623 PULMONARY CONGESTION 46 0.0035
624 HYPOCALCAEMIA 66 0.0035
625 ABDOMINAL PAIN 810 0.0035
626 WEIGHT DECREASED 968 0.0035
627 HYPERGLYCAEMIA 126 0.0035
628 ASTHENIA 1293 0.0034
629 GASTROENTERITIS VIRAL 62 0.0034
630 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
631 OXYGEN SATURATION DECREASED 191 0.0034
632 HYPERTHYROIDISM 49 0.0034
633 BACTERIAL INFECTION 63 0.0034
634 ATRIAL SEPTAL DEFECT 28 0.0033
635 INFUSION SITE PAIN 43 0.0033
636 ARRHYTHMIA 158 0.0033
637 JOINT EFFUSION 23 0.0033
638 PULMONARY OEDEMA 149 0.0033
639 CONSTIPATION 724 0.0033
640 TONGUE DISORDER 24 0.0033
641 LEUKOCYTOSIS 60 0.0033
642 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
643 BLOOD CREATININE INCREASED 214 0.0033
644 UPPER-AIRWAY COUGH SYNDROME 27 0.0033
645 CARDIOGENIC SHOCK 47 0.0033
646 PRURITUS 1252 0.0033
647 HEAD INJURY 103 0.0033
648 SEIZURE 375 0.0032
649 THIRST 58 0.0032
650 EATING DISORDER 69 0.0032
651 MOOD SWINGS 103 0.0032
652 SENSATION OF FOREIGN BODY 27 0.0032
653 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28 0.0032
654 ACUTE RESPIRATORY DISTRESS SYNDROME 56 0.0032
655 SLUGGISHNESS 32 0.0031
656 OCULAR DISCOMFORT 35 0.0031
657 AFFECT LABILITY 30 0.0031
658 REBOUND EFFECT 35 0.0031
659 MUSCLE SPASTICITY 38 0.0031
660 HEPATITIS 79 0.0031
661 MULTIPLE ORGAN DYSFUNCTION SYNDROME 87 0.0031
662 ASPHYXIA 25 0.0031
663 LIMB DISCOMFORT 94 0.0030
664 NEUTROPHIL COUNT INCREASED 31 0.0030
665 MALAISE 1325 0.0030
666 ELECTROLYTE IMBALANCE 35 0.0030
667 SEPTIC SHOCK 130 0.0030
668 CEREBRAL DISORDER 22 0.0030
669 HYPERTENSIVE CRISIS 33 0.0030
670 GAMMA-GLUTAMYLTRANSFERASE INCREASED 65 0.0029
671 FULL BLOOD COUNT ABNORMAL 31 0.0029
672 PRODUCT ADMINISTRATION ERROR 59 0.0029
673 RASH PRURITIC 158 0.0029
674 CARDIOTOXICITY 26 0.0029
675 VENTRICULAR TACHYCARDIA 48 0.0029
676 DRUG INEFFECTIVE 3826 0.0029
677 HYPOGLYCAEMIA 140 0.0029
678 BALANCE DISORDER 248 0.0029
679 IMPAIRED GASTRIC EMPTYING 39 0.0029
680 HYPOTHYROIDISM 91 0.0028
681 PLEURAL EFFUSION 173 0.0028
682 ALANINE AMINOTRANSFERASE INCREASED 174 0.0028
683 FEELING JITTERY 54 0.0028
684 DIABETIC KETOACIDOSIS 68 0.0028
685 BRADYCARDIA 150 0.0028
686 PANIC ATTACK 103 0.0028
687 HEART RATE DECREASED 99 0.0028
688 ANHEDONIA 74 0.0028
689 HEPATIC FUNCTION ABNORMAL 105 0.0028
690 MOVEMENT DISORDER 90 0.0028
691 FALL 931 0.0028
692 PALLOR 76 0.0028
693 BLOOD ALBUMIN DECREASED 22 0.0028
694 LOW BIRTH WEIGHT BABY 22 0.0028
695 FEEDING DISORDER 56 0.0028
696 ANGINA PECTORIS 79 0.0028
697 DIARRHOEA 1779 0.0028
698 NECK PAIN 154 0.0028
699 DYSPNOEA 1557 0.0027
700 NAUSEA 2169 0.0027
701 PRODUCT QUALITY ISSUE 371 0.0027
702 FACE OEDEMA 46 0.0027
703 CARDIAC FAILURE 212 0.0026
704 HOSPICE CARE 26 0.0026
705 ABORTION SPONTANEOUS 105 0.0026
706 LIMB INJURY 71 0.0026
707 RESPIRATORY FAILURE 190 0.0026
708 VENTRICULAR EXTRASYSTOLES 27 0.0026
709 PRODUCTIVE COUGH 124 0.0026
710 NEUROTOXICITY 45 0.0026
711 ANURIA 22 0.0026
712 BLOOD GLUCOSE INCREASED 481 0.0026
713 PRODUCT PRESCRIBING ISSUE 55 0.0025
714 HYPOAESTHESIA ORAL 38 0.0025
715 ANKLE FRACTURE 39 0.0025
716 INFUSION SITE ERYTHEMA 21 0.0025
717 EMOTIONAL DISORDER 76 0.0025
718 MICTURITION URGENCY 28 0.0024
719 RENAL TUBULAR NECROSIS 24 0.0024
720 DYSPHAGIA 231 0.0024
721 LETHARGY 140 0.0024
722 HEREDITARY ANGIOEDEMA 26 0.0024
723 PANCREATITIS ACUTE 54 0.0024
724 EOSINOPHILIA 42 0.0024
725 BLOOD PRESSURE DECREASED 159 0.0024
726 ACUTE RESPIRATORY FAILURE 46 0.0024
727 MYOCARDIAL ISCHAEMIA 27 0.0024
728 ACUTE KIDNEY INJURY 363 0.0024
729 RESPIRATORY RATE INCREASED 21 0.0024
730 HEPATIC ENCEPHALOPATHY 22 0.0024
731 RESPIRATORY TRACT INFECTION 61 0.0023
732 DYSURIA 86 0.0023
733 ILEUS 29 0.0023
734 NEUTROPENIA 317 0.0023
735 HEPATIC FAILURE 70 0.0023
736 LACTIC ACIDOSIS 75 0.0023
737 HEART RATE INCREASED 229 0.0023
738 CRYING 84 0.0023
739 HYPOMAGNESAEMIA 32 0.0023
740 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
741 CARDIOMEGALY 28 0.0023
742 ACUTE HEPATIC FAILURE 31 0.0023
743 FOOT FRACTURE 43 0.0023
744 INFLUENZA LIKE ILLNESS 186 0.0023
745 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 124 0.0023
746 DRUG ERUPTION 40 0.0023
747 DEFORMITY 21 0.0022
748 ECONOMIC PROBLEM 34 0.0022
749 FEELING COLD 62 0.0022
750 NOCTURIA 27 0.0022
751 CHRONIC KIDNEY DISEASE 169 0.0022
752 BLOOD PRESSURE INCREASED 339 0.0022
753 PERICARDIAL EFFUSION 51 0.0022
754 RIB FRACTURE 45 0.0022
755 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 113 0.0022
756 CHOKING 42 0.0022
757 HYPOPHAGIA 55 0.0021
758 ABNORMAL DREAMS 59 0.0021
759 SEASONAL ALLERGY 30 0.0021
760 SWOLLEN TONGUE 66 0.0021
761 PRODUCT DISPENSING ERROR 46 0.0021
762 TOXIC EPIDERMAL NECROLYSIS 32 0.0021
763 OROPHARYNGEAL PAIN 195 0.0021
764 DERMATITIS CONTACT 24 0.0021
765 PHARYNGITIS 26 0.0021
766 RENAL DISORDER 97 0.0021
767 SECRETION DISCHARGE 26 0.0021
768 DRUG RESISTANCE 52 0.0020
769 SYNCOPE 202 0.0020
770 PULMONARY THROMBOSIS 22 0.0020
771 HUNGER 28 0.0020
772 HEART RATE IRREGULAR 45 0.0020
773 DEVICE OCCLUSION 28 0.0020
774 BEDRIDDEN 26 0.0020
775 BLOOD UREA INCREASED 33 0.0020
776 ADVERSE REACTION 26 0.0020
777 NERVOUS SYSTEM DISORDER 61 0.0020
778 DYSSTASIA 57 0.0020
779 ERECTILE DYSFUNCTION 50 0.0019
780 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50 0.0019
781 MUSCULOSKELETAL CHEST PAIN 30 0.0019
782 PHOTOSENSITIVITY REACTION 32 0.0019
783 EYE PAIN 109 0.0019
784 URINARY TRACT INFECTION 329 0.0019
785 INTERNAL HAEMORRHAGE 22 0.0019
786 HEAD DISCOMFORT 34 0.0019
787 END STAGE RENAL DISEASE 35 0.0019
788 BACK PAIN 444 0.0019
789 THERAPEUTIC RESPONSE SHORTENED 63 0.0019
790 ANKYLOSING SPONDYLITIS 25 0.0019
791 FEAR 51 0.0019
792 INTESTINAL OBSTRUCTION 71 0.0019
793 NASAL CONGESTION 109 0.0019
794 BLOOD ALKALINE PHOSPHATASE INCREASED 46 0.0019
795 PRODUCT PRESCRIBING ERROR 44 0.0018
796 RENAL IMPAIRMENT 155 0.0018
797 ASPARTATE AMINOTRANSFERASE INCREASED 98 0.0018
798 IMMUNE SYSTEM DISORDER 24 0.0018
799 SUBDURAL HAEMATOMA 26 0.0018
800 DRUG WITHDRAWAL SYNDROME 158 0.0018
801 SKIN LESION 49 0.0018
802 CONVULSION 101 0.0018
803 SKIN HAEMORRHAGE 26 0.0018
804 VISION BLURRED 240 0.0017
805 ERYTHEMA 358 0.0017
806 HYPERKALAEMIA 61 0.0017
807 DEHYDRATION 232 0.0017
808 CYSTITIS 55 0.0017
809 HOSPITALISATION 259 0.0017
810 FUNGAL INFECTION 56 0.0017
811 HIP FRACTURE 54 0.0017
812 TINNITUS 77 0.0017
813 JAUNDICE 45 0.0017
814 DERMATITIS ALLERGIC 21 0.0017
815 BRAIN FOG 26 0.0017
816 ILLNESS 170 0.0016
817 HAEMORRHOIDS 32 0.0016
818 ORAL HERPES 32 0.0016
819 WHITE BLOOD CELL COUNT DECREASED 177 0.0016
820 PULMONARY EMBOLISM 155 0.0016
821 PALPITATIONS 191 0.0016
822 LUNG NEOPLASM MALIGNANT 67 0.0016
823 PREMATURE BABY 49 0.0016
824 CONJUNCTIVITIS 30 0.0016
825 NEUTROPHIL COUNT DECREASED 65 0.0016
826 ORAL CANDIDIASIS 21 0.0016
827 FRACTURE 30 0.0016
828 POLLAKIURIA 66 0.0016
829 BLOOD GLUCOSE ABNORMAL 29 0.0016
830 COUGH 440 0.0016
831 NEURALGIA 38 0.0016
832 GASTRITIS 41 0.0016
833 DYSPNOEA EXERTIONAL 57 0.0015
834 ORAL DISCOMFORT 21 0.0015
835 PRODUCT SUBSTITUTION ISSUE 87 0.0015
836 ANAEMIA 288 0.0015
837 MASS 21 0.0015
838 JOINT INJURY 32 0.0015
839 CARDIOVASCULAR DISORDER 38 0.0015
840 SENSORY DISTURBANCE 24 0.0015
841 RENAL FAILURE 198 0.0015
842 LIVER FUNCTION TEST ABNORMAL 43 0.0015
843 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
844 INTERNATIONAL NORMALISED RATIO INCREASED 42 0.0015
845 INFLUENZA 164 0.0015
846 IMPAIRED WORK ABILITY 31 0.0014
847 PHOTOPHOBIA 27 0.0014
848 RESPIRATORY DISTRESS 39 0.0014
849 CHOLESTASIS 27 0.0014
850 ABDOMINAL DISTENSION 146 0.0014
851 HAEMOGLOBIN DECREASED 143 0.0014
852 HAEMATOMA 36 0.0014
853 OSTEOPENIA 21 0.0014
854 TOOTHACHE 25 0.0014
855 MOUTH ULCERATION 29 0.0014
856 BLOOD URINE PRESENT 26 0.0014
857 DISEASE RECURRENCE 65 0.0014
858 FEELING ABNORMAL 326 0.0014
859 BURNING SENSATION 95 0.0014
860 SKIN DISCOLOURATION 62 0.0013
861 RASH MACULO-PAPULAR 30 0.0013
862 SKIN CANCER 29 0.0013
863 RENAL INJURY 40 0.0013
864 PRODUCT DOSE OMISSION ISSUE 394 0.0013
865 SWELLING FACE 87 0.0013
866 ASCITES 39 0.0013
867 RESPIRATORY TRACT CONGESTION 21 0.0013
868 DIPLOPIA 34 0.0013
869 MULTI-ORGAN FAILURE 22 0.0013
870 NERVOUSNESS 66 0.0013
871 TOOTH DISORDER 28 0.0013
872 FAECES DISCOLOURED 27 0.0012
873 CANDIDA INFECTION 21 0.0012
874 HEMIPARESIS 21 0.0012
875 INTERVERTEBRAL DISC PROTRUSION 27 0.0012
876 THERAPEUTIC RESPONSE UNEXPECTED 55 0.0012
877 CORONARY ARTERY DISEASE 37 0.0012
878 BLOOD POTASSIUM DECREASED 36 0.0012
879 ECZEMA 62 0.0012
880 HAEMATEMESIS 30 0.0012
881 THROAT TIGHTNESS 32 0.0012
882 RENAL FAILURE ACUTE 50 0.0012
883 MYALGIA 200 0.0012
884 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
885 CELLULITIS 59 0.0012
886 UNEVALUABLE EVENT 88 0.0012
887 INTENTIONAL DOSE OMISSION 33 0.0012
888 BLOOD PRESSURE ABNORMAL 23 0.0012
889 DEEP VEIN THROMBOSIS 75 0.0012
890 RHINORRHOEA 74 0.0011
891 SEPSIS 127 0.0011
892 PANCYTOPENIA 63 0.0011
893 TRANSIENT ISCHAEMIC ATTACK 38 0.0011
894 STEVENS-JOHNSON SYNDROME 25 0.0011
895 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 202 0.0011
896 RED BLOOD CELL COUNT DECREASED 32 0.0011
897 LOCALISED INFECTION 27 0.0011
898 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
899 SKIN DISORDER 37 0.0011
900 PAIN IN JAW 31 0.0011
901 PLATELET COUNT DECREASED 116 0.0011
902 CHEST DISCOMFORT 110 0.0011
903 ATRIAL FIBRILLATION 104 0.0011
904 DRY EYE 53 0.0011
905 CEREBRAL HAEMORRHAGE 38 0.0011
906 TOOTH LOSS 22 0.0011
907 UPPER LIMB FRACTURE 21 0.0011
908 EMOTIONAL DISTRESS 122 0.0010
909 EYE IRRITATION 58 0.0010
910 PAIN OF SKIN 27 0.0010
911 MELAENA 22 0.0010
912 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 202 0.0010
913 COVID-19 172 0.0010
914 CHILLS 114 0.0010
915 ANGIOEDEMA 43 0.0010
916 DRUG DEPENDENCE 156 0.0010
917 DEATH 832 0.0010
918 CARDIAC DISORDER 90 0.0010
919 THROAT IRRITATION 43 0.0010
920 PRODUCT DOSE OMISSION IN ERROR 26 0.0009
921 LYMPHADENOPATHY 32 0.0009
922 GASTROINTESTINAL HAEMORRHAGE 75 0.0009
923 LIP SWELLING 29 0.0009
924 MULTIPLE SCLEROSIS 41 0.0009
925 DRUG EXPOSURE DURING PREGNANCY 29 0.0009
926 HAEMATOCHEZIA 47 0.0009
927 EYE SWELLING 31 0.0008
928 ANAPHYLACTIC REACTION 46 0.0008
929 RASH MACULAR 28 0.0008
930 BLINDNESS 32 0.0008
931 VISUAL ACUITY REDUCED 26 0.0008
932 ACUTE MYOCARDIAL INFARCTION 23 0.0008
933 DEVICE DISLOCATION 33 0.0008
934 GASTRIC DISORDER 26 0.0008
935 EPISTAXIS 56 0.0007
936 GYNAECOMASTIA 23 0.0007
937 NO ADVERSE EVENT 134 0.0007
938 CATARACT 44 0.0007
939 BONE DENSITY DECREASED 23 0.0007
940 LACRIMATION INCREASED 22 0.0007
941 NEEDLE ISSUE 21 0.0007
942 DYSPHONIA 42 0.0007
943 MYOCARDIAL INFARCTION 124 0.0007
944 MULTIPLE SCLEROSIS RELAPSE 48 0.0007
945 EYE DISORDER 23 0.0007
946 NEPHROLITHIASIS 32 0.0007
947 CARDIAC FAILURE CONGESTIVE 56 0.0007
948 THROMBOSIS 56 0.0007
949 HOT FLUSH 52 0.0007
950 FLATULENCE 39 0.0007
951 HERPES ZOSTER 39 0.0007
952 SKIN EXFOLIATION 57 0.0007
953 HAEMORRHAGE 70 0.0007
954 PRODUCT DOSE OMISSION 43 0.0007
955 INJECTION SITE BRUISING 52 0.0007
956 FEBRILE NEUTROPENIA 43 0.0006
957 CEREBROVASCULAR ACCIDENT 108 0.0006
958 VIRAL INFECTION 21 0.0006
959 ACNE 47 0.0006
960 COLITIS 23 0.0006
961 BLOOD GLUCOSE DECREASED 29 0.0006
962 NEUROPATHY PERIPHERAL 57 0.0006
963 EXTRA DOSE ADMINISTERED 24 0.0006
964 OCULAR HYPERAEMIA 28 0.0006
965 DRY SKIN 78 0.0006
966 INCORRECT DOSE ADMINISTERED 130 0.0006
967 INJECTION SITE MASS 21 0.0006
968 THERAPY CESSATION 29 0.0006
969 SURGERY 33 0.0006
970 HYPOACUSIS 24 0.0006
971 FLUSHING 56 0.0006
972 BONE PAIN 32 0.0005
973 INTERSTITIAL LUNG DISEASE 26 0.0005
974 SKIN BURNING SENSATION 38 0.0005
975 DEVICE ISSUE 44 0.0005
976 INJECTION SITE HAEMORRHAGE 39 0.0005
977 INJECTION SITE REACTION 32 0.0005
978 THERAPY INTERRUPTED 33 0.0005
979 DYSGEUSIA 34 0.0005
980 DISEASE PROGRESSION 49 0.0004
981 DRUG EFFECT DECREASED 22 0.0004
982 ACCIDENTAL EXPOSURE TO PRODUCT 42 0.0004
983 INJECTION SITE PAIN 124 0.0004
984 NEOPLASM MALIGNANT 26 0.0004
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 26 0.0004
986 DRUG DOSE OMISSION 55 0.0003
987 INJECTION SITE PRURITUS 21 0.0003
988 INJECTION SITE SWELLING 23 0.0003
989 INJECTION SITE ERYTHEMA 30 0.0002